메뉴 건너뛰기




Volumn 30, Issue 10, 2003, Pages 786-792

Different remodelling against left ventricular overload between diabetic and non-diabetic haemodialysis patients

Author keywords

B type natriuretic peptide; Congestive heart failure; Diabetes mellitus; End stage renal disease; Haemodialysis; Left ventricular hypertrophy; Remodelling

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EID: 10744229553     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03914.x     Document Type: Article
Times cited : (6)

References (36)
  • 2
    • 0028313403 scopus 로고
    • Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients
    • Harnett JD, Knet GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients. J. Am. Soc. Nephrol. 1994; 1: 1486-90.
    • (1994) J. Am. Soc. Nephrol. , vol.1 , pp. 1486-1490
    • Harnett, J.D.1    Knet, G.M.2    Barre, P.E.3    Taylor, R.4    Parfrey, P.S.5
  • 4
    • 0028953102 scopus 로고
    • Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
    • Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884-90.
    • (1995) Kidney Int. , vol.47 , pp. 884-890
    • Harnett, J.D.1    Foley, R.N.2    Kent, G.M.3    Barre, P.E.4    Murray, D.5    Parfrey, P.S.6
  • 5
    • 0018965458 scopus 로고
    • Cardiac hypertrophy: Useful adaptation or pathological process?
    • Grossman W. Cardiac hypertrophy: Useful adaptation or pathological process? Am. J. Med. 1989; 69: 576-84.
    • (1989) Am. J. Med. , vol.69 , pp. 576-584
    • Grossman, W.1
  • 6
    • 0034751209 scopus 로고    scopus 로고
    • A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients
    • Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am. J. Kidney Dis. 2001; 38: 992-1000.
    • (2001) Am. J. Kidney Dis. , vol.38 , pp. 992-1000
    • Stack, A.G.1    Bloembergen, W.E.2
  • 7
    • 0035132108 scopus 로고    scopus 로고
    • Cause and management of heart failure in patients with chronic renal disease
    • Al-Ahmad A, Sarnak MJ, Salem DN, Konstam MA. Cause and management of heart failure in patients with chronic renal disease. Semin. Nephrol. 2001; 21: 3-12.
    • (2001) Semin. Nephrol. , vol.21 , pp. 3-12
    • Al-Ahmad, A.1    Sarnak, M.J.2    Salem, D.N.3    Konstam, M.A.4
  • 8
    • 0025729993 scopus 로고
    • Brain natriutetic peptide as a novel cardiac hormone in humans
    • Mukoyama M, Nakao K, Hosoda K et al. Brain natriutetic peptide as a novel cardiac hormone in humans. J. Clin. Invest. 1991; 87: 1402-12.
    • (1991) J. Clin. Invest. , vol.87 , pp. 1402-1412
    • Mukoyama, M.1    Nakao, K.2    Hosoda, K.3
  • 9
    • 0028359997 scopus 로고
    • Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patietns with heart failure
    • Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patietns with heart failure. Circulation 1994; 90: 195-203.
    • (1994) Circulation , vol.90 , pp. 195-203
    • Yasue, H.1    Yoshimura, M.2    Sumida, H.3
  • 10
    • 0029834931 scopus 로고    scopus 로고
    • Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
    • Yamamoto K, Burnett Jr JC, Jougasaki M et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-94.
    • (1996) Hypertension , vol.28 , pp. 988-994
    • Yamamoto, K.1    Burnett J.C., Jr.2    Jougasaki, M.3
  • 11
    • 0031693057 scopus 로고    scopus 로고
    • Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis
    • Nitta K, Kawashima A, Yumura W et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am. J. Nephrol 1998; 18: 411-15.
    • (1998) Am. J. Nephrol , vol.18 , pp. 411-415
    • Nitta, K.1    Kawashima, A.2    Yumura, W.3
  • 12
    • 0035069834 scopus 로고    scopus 로고
    • Diagnostic potential of cardiac natriuretic peptide in dialysis patients
    • Mallamaci F, Zoccali C, Tripepi G et al. Diagnostic potential of cardiac natriuretic peptide in dialysis patients. Kidney Int. 2001; 59: 1559-66.
    • (2001) Kidney Int. , vol.59 , pp. 1559-1566
    • Mallamaci, F.1    Zoccali, C.2    Tripepi, G.3
  • 13
    • 0018231715 scopus 로고
    • The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements
    • Sahn DJ, DeMaria A, Kisso J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
    • (1978) Circulation , vol.58 , pp. 1072-1083
    • Sahn, D.J.1    DeMaria, A.2    Kisso, J.3    Weyman, A.4
  • 14
    • 0027258966 scopus 로고
    • Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease
    • Devereux RB, Koren MJ, deSimone G, Okin PM, Kligfield P. Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur. Heart J. 1993; 14 (Suppl. D): 8-15.
    • (1993) Eur. Heart J. , vol.14 , Issue.SUPPL. D , pp. 8-15
    • Devereux, R.B.1    Koren, M.J.2    DeSimone, G.3    Okin, P.M.4    Kligfield, P.5
  • 15
    • 0025159069 scopus 로고
    • Left ventricular hypertrophy in men with normal blood pressure: Relation to exaggerated blood pressure response to exercise
    • Gottdiener JS, Brown J, Zoltick J, Fletcher RD. Left ventricular hypertrophy in men with normal blood pressure: Relation to exaggerated blood pressure response to exercise. Ann. Intern. Med. 1990; 112: 161-6.
    • (1990) Ann. Intern. Med. , vol.112 , pp. 161-166
    • Gottdiener, J.S.1    Brown, J.2    Zoltick, J.3    Fletcher, R.D.4
  • 16
    • 0030741179 scopus 로고    scopus 로고
    • Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone
    • Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J. Am. Coll. Cardiol. 1997; 30: 8-18.
    • (1997) J. Am. Coll. Cardiol. , vol.30 , pp. 8-18
    • Nishimura, R.A.1    Tajik, A.J.2
  • 17
    • 0034765282 scopus 로고    scopus 로고
    • Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling
    • Cataliotti A, Malatino LS, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin. Proc. 2001; 76: 1111-19.
    • (2001) Mayo Clin. Proc. , vol.76 , pp. 1111-1119
    • Cataliotti, A.1    Malatino, L.S.2    Jougasaki, M.3
  • 18
    • 0031772642 scopus 로고    scopus 로고
    • Measurement and significance of circulating natriuretic peptides in cardiovascular disease
    • Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin. Sci. 1998; 95: 519-29.
    • (1998) Clin. Sci. , vol.95 , pp. 519-529
    • Sagnella, G.A.1
  • 19
    • 0026781270 scopus 로고
    • Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure
    • Buckley MG, Sethi D, Markandu ND et al. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin. Sci. 1992; 83: 437-44.
    • (1992) Clin. Sci. , vol.83 , pp. 437-444
    • Buckley, M.G.1    Sethi, D.2    Markandu, N.D.3
  • 20
    • 0027298699 scopus 로고
    • Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes
    • Yamazaki T, Tobe K, Hoh E et al. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J. Biol. Chem. 1993; 268: 12 069-76.
    • (1993) J. Biol. Chem. , vol.268 , pp. 12069-12076
    • Yamazaki, T.1    Tobe, K.2    Hoh, E.3
  • 21
    • 0029090205 scopus 로고
    • Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes
    • Yamazaki T, Komuro I, Kudoh S et al. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 1995; 96: 438-46.
    • (1995) J. Clin. Invest. , vol.96 , pp. 438-446
    • Yamazaki, T.1    Komuro, I.2    Kudoh, S.3
  • 22
    • 0027722248 scopus 로고
    • Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo
    • Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vivo. Cell 1993; 75: 977-84.
    • (1993) Cell , vol.75 , pp. 977-984
    • Sadoshima, J.1    Xu, Y.2    Slayter, H.S.3    Izumo, S.4
  • 23
    • 0027182438 scopus 로고
    • Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts
    • Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ. Res. 1993; 73: 413-23.
    • (1993) Circ. Res. , vol.73 , pp. 413-423
    • Sadoshima, J.1    Izumo, S.2
  • 24
    • 0028206850 scopus 로고
    • Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro
    • Kojima M, Shiojima I, Yamazaki T et al. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 1994; 89: 2204-11.
    • (1994) Circulation , vol.89 , pp. 2204-2211
    • Kojima, M.1    Shiojima, I.2    Yamazaki, T.3
  • 25
    • 0027257160 scopus 로고
    • Endothelin-1 is an autocine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
    • Ito H, Hirata Y, Adachi S et al. Endothelin-1 is an autocine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 1993; 92: 398-403.
    • (1993) J. Clin. Invest. , vol.92 , pp. 398-403
    • Ito, H.1    Hirata, Y.2    Adachi, S.3
  • 26
    • 0028182649 scopus 로고
    • Endothelin ETA antagonist blocks cardiac hypertrophy provoked by hemodynamic overload
    • Ito H, Hiroe M, Hirata Y et al. Endothelin ETA antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 1994; 89: 2198-203.
    • (1994) Circulation , vol.89 , pp. 2198-2203
    • Ito, H.1    Hiroe, M.2    Hirata, Y.3
  • 27
    • 0027302878 scopus 로고
    • Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions
    • Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T. Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions. Am. J. Epidemiol. 1993; 137: 1328-40.
    • (1993) Am. J. Epidemiol. , vol.137 , pp. 1328-1340
    • Burchfiel, C.M.1    Reed, D.M.2    Marcus, E.B.3    Strong, J.P.4    Hayashi, T.5
  • 28
    • 0026506429 scopus 로고
    • Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease
    • Perez JE, McGill JB, Santiago JV et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J. Am. Coll. Cardiol. 1992; 19: 1154-62.
    • (1992) J. Am. Coll. Cardiol. , vol.19 , pp. 1154-1162
    • Perez, J.E.1    McGill, J.B.2    Santiago, J.V.3
  • 29
    • 0028946936 scopus 로고
    • Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study
    • DiBello V, Talarico L, Picano E et al. Increased echodensity of myocardial wall in the diabetic heart: An ultrasound tissue characterization study. J. Am. Coll. Cardiol. 1995; 25: 1408-15.
    • (1995) J. Am. Coll. Cardiol. , vol.25 , pp. 1408-1415
    • DiBello, V.1    Talarico, L.2    Picano, E.3
  • 30
    • 0033974161 scopus 로고    scopus 로고
    • Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
    • Hayashi T, Suzuki A, Shoji T et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am. J. Kidney Dis. 2000; 35: 250-6.
    • (2000) Am. J. Kidney Dis. , vol.35 , pp. 250-256
    • Hayashi, T.1    Suzuki, A.2    Shoji, T.3
  • 31
    • 0025357286 scopus 로고
    • Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
    • Silberberg J, Racine N, Barre P, Sniderman AD. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can. J. Cardiol. 1990; 6: 1-4.
    • (1990) Can. J. Cardiol. , vol.6 , pp. 1-4
    • Silberberg, J.1    Racine, N.2    Barre, P.3    Sniderman, A.D.4
  • 32
    • 0029972850 scopus 로고    scopus 로고
    • Progesterone binding to mineralocorticoid receptors: In vitro and in vivo studies
    • Myles K, Funder JW. Progesterone binding to mineralocorticoid receptors: In vitro and in vivo studies. Am. J. Physiol. 1996; 270: E601-7.
    • (1996) Am. J. Physiol. , vol.270
    • Myles, K.1    Funder, J.W.2
  • 33
    • 0023221667 scopus 로고
    • Cloning of human mineralocorticoid receptor complementary DNA. Structural and functinal kinship with the glucocorticoid receptors
    • Arriza JL, Weinberger C, Cerelli G et al. Cloning of human mineralocorticoid receptor complementary DNA. Structural and functinal kinship with the glucocorticoid receptors. Science 1987; 237: 268-75.
    • (1987) Science , vol.237 , pp. 268-275
    • Arriza, J.L.1    Weinberger, C.2    Cerelli, G.3
  • 34
    • 0028785677 scopus 로고
    • Determination of cardiac fibrosis in experimental hypermineralocorticoid states
    • Young M, Head J, Funder JW. Determination of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 1995; 269: E657-62.
    • (1995) Am. J. Physiol. , vol.269
    • Young, M.1    Head, J.2    Funder, J.W.3
  • 36
    • 0032885976 scopus 로고    scopus 로고
    • Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis
    • Sato A, Funder JW, Saruta T. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis. Am. J. Hypertens. 1999; 12: 867-73.
    • (1999) Am. J. Hypertens. , vol.12 , pp. 867-873
    • Sato, A.1    Funder, J.W.2    Saruta, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.